We are pleased, to be able to offer a groundbreaking technique doctors and patients, which reduces the need for postoperative drainage and has a positive effect on treatment outcomes of patients.” Cohera medical received the CE marking for TissuGlu in September 2011, and has started with the sale of products to hospitals and doctors in Germany. In 2012, the company plans the expansion of market availability of TissuGlu in other European markets. TissuGlu is successfully used by leading surgeons in various surgical procedures. Information about Cohera medical Cohera medical, Inc. is a leading innovator and developer of absorbable surgical adhesives and sealant. The first product the company, the surgical adhesive TissuGlu, is a surgical adhesive for internal use at large cloth operations such as such as Abdominoplasty (Tummy Tuck), which helps to reduce the fluid retention and the need for postoperative drainage or eliminate.
The chemical composition of TissuGlu is absorbable and non-toxic, establishes a strong connection between the fabric layers and a natural cure, enabling a faster recovery can take place. TissuGlu has received the CE mark for distribution in the European Union. Cohera medical also developed a unique, registered colon sealant and a strong adhesive for the fixation of surgical networks. TissuGlu and the other Cohera products are currently outside the EU intended for testing purposes only and were not yet approved by the FDA (food and Drug Administration) approved for sale in the United States and other countries. For more information see. Some statements in This press release that describe historical facts, contain forward-looking statements about the future plans, objectives and expected results of the company. Such forward-looking statements are based on assumptions that keeps the company for reasonable, which, however, are subject to a number of risks and uncertainties. It can not ensure therefore that results actually obtained differ not much of which, explicitly or implicitly given in such forward-looking statements.